Full Coverage

Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole,...

primenewswire.com
May 22, 2008
        
Story Timeline:  196 days

PRINCETON, N.J., May 22, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of therapeutic dermatology, announced that it will package its seborrheic dermatitis treatment Xolegel(r) (ketoconazole, USP)... [read full story]                    

Add Comment
Latest article on this story:

P&G, Barrier Therapeutics team on Rx dermatitis kit (at bizjournals.com)

 yahoo.com May 22, 2008
First article on this story:

Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole,...

 primezone.com May 22, 2008
Selected publications with coverage of this story:
ibtimes.com primenewswire.com yahoo.com primezone.com
RELATED
Found 5 documents:

P&G, Barrier Therapeutics team on Rx dermatitis kit (at bizjournals.com)

yahoo.com
May 22, 2008
        

Business Courier of Cincinnati have signed a deal to combine P&G's Head & Shoulders shampoo in a kit with Barrier's Xolegel dermatitis treatment. The kit will be available by prescription beginning in June, according to an Associated Press story. Barrier will manufacture and sell the kits, to be...

Barrier Therapeutics, Procter & Gamble sign deal (AP)

yahoo.com
May 22, 2008
        

Thursday May 22, 8:20 am ET Barrier Therapeutics, Procter & Gamble sign deal to sell shampoo and skin gel together PRINCETON, N.J. (AP) -- Dermatology products maker Barrier Therapeutics Inc. on Thursday said it signed a deal to sell its dermatitis treatment Xolegel together with Procter &...

Barrier Therapeutics, Procter & Gamble sign deal

ibtimes.com
May 22, 2008
        

PRINCETON, N.J. (AP) - Dermatology products maker Barrier Therapeutics Inc. on Thursday said it signed a deal to sell its dermatitis treatment Xolegel together with Procter & Gamble's dandruff shampoo Head & Shoulders. The kit, known as Xolegel Duo, is expected to be available by prescription in...

Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole,...

yahoo.com
May 22, 2008
        

Thursday May 22, 7:30 am ET Latest Offering for Seborrheic Dermatitis of Face, Body and Scalp Soon to be Marketed and Sold by Barrier Therapeutics PRINCETON, N.J., May 22, 2008 (PRIME NEWSWIRE) -- News), a pharmaceutical company developing and commercializing products in the field of therapeutic...

Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole,...

primezone.com
May 22, 2008
        

PRINCETON, N.J., May 22, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of therapeutic dermatology, announced that it will package its seborrheic dermatitis treatment Xolegel(r) (ketoconazole, USP)...